MetaCap

Hinge Health Inc. Class A (HNGE)

NYSE: HNGETechnologyEDP ServicesUSD

98.00+0.14 (+0.14%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 98.00 0.00%

HNGE stock chart

Technical analysis

Key statistics

All statistics
52-week range
30.08 – 100.36
Day range
96.05 – 98.73
Volume / Avg
908.71K / 1.83M
Beta
—
Next earnings
Nov 2, 2026

52-week range

$30.08$100.36

HNGE stock today

Shares of Hinge Health (HNGE) finished higher on Oct 8 at $98.00, a gain of 0.14% or $0.14 per share, versus the S&P 500's 0.47% decline. Trading was light, with 908.71K shares changing hands, about 50% of the average daily volume. At this level, HNGE sits near the top of its 52-week range of $30.08 to $100.36: 2.4% below the high, set on Oct 6, 2026 and 225.8% above the low.

HNGE is up 110.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 91.3%. At 32.3x trailing earnings, Hinge Health trades above the peer-group median of 17.7x. Its forward P/E of 32.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Hinge Health's next earnings report is expected on Nov 2, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Hinge Health

Company profile

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.

Industry
EDP Services
CEO
Mr. Daniel A. Perez
Headquarters
San Francisco, CA
Employees
1,437
IPO year
2025

Financial highlights

Full financials

In fiscal 2025, Hinge Health generated $587.9 million in revenue, up 50.6% from fiscal 2024, its 2nd consecutive year of revenue growth. Hinge Health reported a net loss of $528.3 million, compared with a loss of $11.9 million a year earlier. Gross margin was 79.6% (up from 76.8%) and operating margin -92.9%.

Hinge Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue$587.86M$390.40M$292.73M
Growth+50.58%+33.37%—
Net income$-528.26M$-11.93M$-108.14M
EPS (diluted)$-7.77$-0.88$-8.31

Analyst forecast

Forecast

Consensus (17 analysts)

buy

Avg. price target

$110.56+12.82%

  • Strong buy 7
  • Buy 9
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $90.00High $140.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 2, 2026
EPS estimate
$0.27
Last reported (Q2 2026)
Aug 6, 2026
EPS actual vs est.
$0.52 vs —

HNGE news

All HNGE news

Hinge Health peers

Technology sector
HNGE peer companies
CompanyPrice% ChgMarket capCompare
APLDApplied Digital Corporation23.85+0.17%$7.14Bvs HNGE
RNGRingCentral Inc. Class A78.35+2.36%$6.54Bvs HNGE
DOXAmdocs Limited60.25+2.56%$6.29Bvs HNGE
BILIBilibili Inc. ADR14.85-0.47%$6.12Bvs HNGE
EPAMEPAM Systems Inc.113.86+5.11%$5.87Bvs HNGE
PEGAPegasystems Inc.35.49+3.32%$5.83Bvs HNGE
OTEXOpen Text Corporation23.24+0.43%$5.64Bvs HNGE
QBTSD-Wave Quantum Inc.14.60-4.07%$5.54Bvs HNGE

Indexes, lists and sector

Hinge Health stock FAQ

What is Hinge Health's stock price today?

HNGE last traded at $98.00 as of Oct 8, 4:00 PM EDT, up 0.14% on the day. Prices are delayed at least 15 minutes.

When is Hinge Health's next earnings date?

Hinge Health is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $0.27.

What is HNGE's P/E ratio?

HNGE trades at a trailing P/E ratio of 32.34 and a forward P/E of 32.05, compared with a median of 17.7 for its closest peers.

Who is Hinge Health's CEO?

Mr. Daniel A. Perez is the chief executive officer of Hinge Health Inc. Class A, which has about 1,437 employees.

What is the HNGE 52-week high?

The 52-week high for HNGE is $100.36 and the 52-week low is $30.08. The stock is currently 2.4% below its high.

Compare HNGE